Related Experiment Video
Updated: Jun 16, 2026

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
Published on: February 25, 2011
Chemotherapeutic drugs inhibit ribosome biogenesis at various levels
Kaspar Burger1, Bastian Mühl, Thomas Harasim
1Institute for Clinical Molecular Biology and Tumor Genetics, Center for Integrated Protein Science Munich (CIPSM), Germany.
Abstract:
Drugs for cancer therapy belong to different categories of chemical substances. The cellular targets for the therapeutic efficacy are often not unambiguously identified. Here, we describe the process of ribosome biogenesis as a target of a large variety of chemotherapeutic drugs. We determined the inhibitory concentration of 36 chemotherapeutic drugs for transcription and processing of ribosomal RNA by in vivo labeling experiments. Inhibitory drug concentrations were correlated to the loss of nucleolar integrity. The synergism of drugs inhibiting ribosomal RNA synthesis at different levels was studied. Drugs inhibited ribosomal RNA synthesis either at the level of (i) rRNA transcription (e.g. oxaliplatin, doxorubicin, mitoxantrone, methotrexate), (ii) early rRNA processing (e.g. camptothecin, flavopiridol, roscovitine), or (iii) late rRNA processing (e.g. 5-fluorouracil, MG-132, homoharringtonine). Blockage of rRNA transcription or early rRNA processing steps caused nucleolar disintegration, whereas blockage of late rRNA processing steps left the nucleolus intact. Flavopiridol and 5-fluorouracil showed a strong synergism for inhibition of rRNA processing. We conclude that inhibition of ribosome biogenesis by chemotherapeutic drugs potentially may contribute to the efficacy of therapeutic regimens.
Insights
Chemotherapeutic drugs target ribosome biogenesis, impacting cancer therapy efficacy. Inhibiting ribosomal RNA (rRNA) synthesis at different stages affects nucleolar integrity and drug synergism.
Area of Science:
- Molecular Biology
- Cancer Therapeutics
- Cellular Biology
Background:
- Cancer drugs have diverse chemical classes and targets.
- The precise cellular targets of many chemotherapeutics remain unclear.
- Ribosome biogenesis is a critical cellular process often affected by cancer therapies.
Purpose of the Study:
- To investigate ribosome biogenesis as a target for chemotherapeutic drugs.
- To determine the inhibitory concentrations of 36 drugs on ribosomal RNA (rRNA) synthesis and processing.
- To explore drug synergism and the impact on nucleolar integrity.
Main Methods:
- In vivo labeling experiments to measure rRNA transcription and processing.
- Determination of inhibitory drug concentrations.
- Correlation of drug effects with nucleolar integrity and assessment of drug synergism.
Main Results:
- 36 chemotherapeutic drugs were tested for their inhibitory effects on rRNA synthesis and processing.
- Drugs were categorized by their inhibition site: rRNA transcription, early rRNA processing, or late rRNA processing.
- Inhibition of transcription or early processing led to nucleolar disintegration; late processing inhibition did not.
- Flavopiridol and 5-fluorouracil demonstrated strong synergism in inhibiting rRNA processing.
Conclusions:
- Chemotherapeutic drugs can inhibit ribosome biogenesis at various stages.
- The level of inhibition (transcription, early vs. late processing) impacts nucleolar integrity.
- Inhibition of ribosome biogenesis may contribute to the overall efficacy of cancer chemotherapy.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of RNA
RNA Performs Diverse...
Drugs that Destabilize Microtubules
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...

